Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (7)

2021

  1. Erratum: Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19 (Journal of Perinatal Medicine (2020) 48:9 (950-958) DOI: 10.1515/jpm-2020-0355)

    Journal of Perinatal Medicine

  2. Gestational age-specific reference ranges for the sFlt-1/PlGF immunoassay ratio in twin pregnancies

    Fetal Diagnosis and Therapy, Vol. 48, Núm. 4, pp. 288-296

  3. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection

    Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 232-241

2020

  1. A more accurate prediction to rule in and rule out pre-eclampsia using the sFlt-1/PlGF ratio and NT-proBNP as biomarkers

    Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 3, pp. 399-407

  2. Maternal and perinatal outcomes associated with extremely high values for the sflt-1 (Soluble fms-like tyrosine kinase 1)/plgf (placental growth factor) ratio

    Journal of the American Heart Association, Vol. 9, Núm. 7

  3. Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19

    Journal of Perinatal Medicine, Vol. 48, Núm. 9, pp. 950-958

2018

  1. Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1/PlGF Ratio in Singleton Pregnancies

    Fetal Diagnosis and Therapy, Vol. 43, Núm. 2, pp. 81-89